下一代基于核酸的病毒病原体诊断:从SARS-CoV-2大流行中吸取的教训
Amy Papaneri1, Guohong Cui1, Shih-Heng Chen2
1In Vivo Neurobiology Group, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, Durham, NC 27709, USA.
Microorganisms
|August 28, 2025
概括
新一代的分子诊断技术,如CRISPR和生物传感器, 可以更快,更灵敏地检测病原体. 本次审查分析了它们的战略和经济可行性,以应对未来的流行病,并强调了节省成本的好处.
科学领域:
- 分子诊断
- 疫情防控工作
- 生物技术
背景情况:
- COVID-19 疫情凸显了快速,敏感的病原体检测的需要.
- 传统的PCR在速度和治疗场所的应用方面存在局限性.
- 基于CRISPR的系统,同热放大和生物传感器提供先进的核酸检测.
研究的目的:
- 分析将下一代诊断技术整合到流行病应对管道中的可行性,可扩展性和经济效益.
- 综合新冠肺炎诊断平台的进展,并评估它们在高需求期间的成本节约潜力.
- 将CRISPR-Cas与RPA等技术转化为新出现的病毒威胁的第一线诊断管道.
主要方法:
- 对分子诊断技术的最新进展进行审查和综合.
- 分析影响实际实施的战略和经济因素.
- 评估CRISPR-Cas与重组酶聚合酶放大 (RPA) 的整合.
主要成果:
- 与PCR相比,CRISPR,同热放大和生物传感器显示出更好的速度,灵敏度和临床使用.
- 广泛实施存在重大战略和经济障碍.
- 结合CRISPR-Cas和RPA, 提供了一个可行的诊断管道.
结论:
- 下一代诊断对于有效应对流行病至关重要.
- 应对实施挑战是利用这些技术的关键.
- 战略部署可以节省成本并改善公共卫生结果.
相关概念视频
Viral Mutations
33.2K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
33.2K
Single Nucleotide Polymorphisms-SNPs
14.8K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
14.8K


